CIK 0001576280
GH Guardant Health, Inc.
Insider trading from SEC Form 4. Last filing Dec 19, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Signals
Open-market buys and sells at Guardant Health, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 0Weak | sell10b5-1 | Tariq Musa director | $4,043 | 116 | -4% | - | |
| 7Weak | sell 210b5-1 | Tariq Musa director | $81k | 2,320 | -46% | - | |
| 10Weak | sell 310b5-1 | Joyce Meghan V. director | $3,590 | 100 | -1% | - | |
| 52Moderate | sell 3 | Kalia Kumud Chief Information Officer | $205k | 7,000 | -28% | - | |
| 38Weak | sell 3 | CLARK IAN T director | $245k | 8,318 | -50% | - | |
| 29Weak | sell 310b5-1 | Joyce Meghan V. director | $87k | 2,896 | -27% | - |
Congressional trades
1 trade in GH disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Sheldon Whitehouse Senate · D-RI | Purchase | GH Guardant Health Inc | $1,001 to $15k | Nov 21, 2025 | 10 days after the trade |
Transactions
The last 76 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | Tariq Musa director | SOpen-market sale Common Stock10b5-1 | -116 | $34.85 | $4,043 | 2,810 | Dec 19, 2024 |
| Dec 15, 2024 | Bell Michael Brian Chief Financial Officer | MOption exercise Common Stock | +1,233 | $0.00 | $0 | 25,308 | Dec 16, 2024 |
| Dec 13, 2024 | Tariq Musa director | SOpen-market sale Common Stock10b5-1 | -2,320 | $35.00 | $81k | 2,676 | Dec 16, 2024 |
| Dec 15, 2024 | Saia John G. Chief Legal Officer | MOption exercise Common Stock | +1,020 | $0.00 | $0 | 34,095 | Dec 16, 2024 |
| Dec 15, 2024 | EAGLE CRAIG Chief Medical Officer | MOption exercise Common Stock | +1,402 | $0.00 | $0 | 24,673 | Dec 16, 2024 |
| Dec 15, 2024 | POTTER MYRTLE S director | MOption exercise Common Stock | +69 | $0.00 | $0 | 13,722 | Dec 16, 2024 |
| Dec 15, 2024 | Freeman Chris Chief Commercial Officer | MOption exercise Common Stock | +1,402 | $0.00 | $0 | 32,854 | Dec 16, 2024 |
| Dec 15, 2024 | Kalia Kumud Chief Information Officer | MOption exercise Common Stock | +637 | $0.00 | $0 | 18,731 | Dec 16, 2024 |
| Dec 15, 2024 | Saia John G. Chief Legal Officer | FTax withholding Common Stock | -535 | $34.76 | $19k | 33,560 | Dec 16, 2024 |
| Dec 15, 2024 | POTTER MYRTLE S director | MOption exercise Restricted Stock Unitsderivative | -69 | $0.00 | $0 | 684 | Dec 16, 2024 |
| Dec 15, 2024 | Kalia Kumud Chief Information Officer | FTax withholding Common Stock | -323 | $34.76 | $11k | 18,408 | Dec 16, 2024 |
| Dec 15, 2024 | Tariq Musa director | MOption exercise Common Stock10b5-1 | +250 | $0.00 | $0 | 2,926 | Dec 16, 2024 |
| Dec 15, 2024 | Freeman Chris Chief Commercial Officer | FTax withholding Common Stock | -597 | $34.76 | $21k | 32,257 | Dec 16, 2024 |
| Dec 15, 2024 | EAGLE CRAIG Chief Medical Officer | FTax withholding Common Stock | -711 | $34.76 | $25k | 23,962 | Dec 16, 2024 |
| Dec 15, 2024 | Bell Michael Brian Chief Financial Officer | MOption exercise Common Stock | +2,039 | $0.00 | $0 | 27,347 | Dec 16, 2024 |
| Dec 15, 2024 | Tariq Musa director | MOption exercise Restricted Stock Unitsderivative10b5-1 | -250 | $0.00 | $0 | 6,746 | Dec 16, 2024 |
| Dec 15, 2024 | Freeman Chris Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative | -1,402 | $0.00 | $0 | 8,411 | Dec 16, 2024 |
| Dec 15, 2024 | Bell Michael Brian Chief Financial Officer | FTax withholding Common Stock | -1,659 | $34.76 | $58k | 25,688 | Dec 16, 2024 |
| Dec 15, 2024 | Saia John G. Chief Legal Officer | MOption exercise Restricted Stock Unitsderivative | -1,020 | $0.00 | $0 | 6,117 | Dec 16, 2024 |
| Dec 15, 2024 | Kalia Kumud Chief Information Officer | MOption exercise Restricted Stock Unitsderivative | -637 | $0.00 | $0 | 3,824 | Dec 16, 2024 |
| Dec 15, 2024 | EAGLE CRAIG Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | -1,402 | $0.00 | $0 | 8,411 | Dec 16, 2024 |
| Dec 15, 2024 | Bell Michael Brian Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,233 | $0.00 | $0 | 6,165 | Dec 16, 2024 |
| Dec 15, 2024 | Bell Michael Brian Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -2,039 | $0.00 | $0 | 12,234 | Dec 16, 2024 |
| Dec 4, 2024 | Joyce Meghan V. director | MOption exercise Common Stock | +67 | $0.00 | $0 | 7,615 | Dec 5, 2024 |
| Dec 4, 2024 | Joyce Meghan V. director | MOption exercise Restricted Stock Unitsderivative | -67 | $0.00 | $0 | 531 | Dec 5, 2024 |
| Dec 2, 2024 | Joyce Meghan V. director | SOpen-market sale Common Stock10b5-1 | -100 | $35.90 | $3,590 | 7,548 | Dec 3, 2024 |
| Dec 1, 2024 | Chudova Darya Chief Technology Officer | MOption exercise Common Stock | +316 | $0.00 | $0 | 54,941 | Dec 2, 2024 |
| Nov 30, 2024 | Krognes Steve E. director | MOption exercise Common Stock | +154 | $0.00 | $0 | 10,065 | Dec 2, 2024 |
| Dec 1, 2024 | Saia John G. Chief Legal Officer | MOption exercise Common Stock | +263 | $0.00 | $0 | 33,213 | Dec 2, 2024 |
| Dec 1, 2024 | Kalia Kumud Chief Information Officer | MOption exercise Common Stock | +710 | $0.00 | $0 | 18,454 | Dec 2, 2024 |
| Dec 1, 2024 | Kalia Kumud Chief Information Officer | FTax withholding Common Stock | -360 | $35.61 | $13k | 18,094 | Dec 2, 2024 |
| Dec 1, 2024 | Saia John G. Chief Legal Officer | FTax withholding Common Stock | -138 | $35.61 | $4,914 | 33,075 | Dec 2, 2024 |
| Dec 1, 2024 | Chudova Darya Chief Technology Officer | FTax withholding Common Stock | -161 | $35.61 | $5,733 | 54,780 | Dec 2, 2024 |
| Nov 30, 2024 | Krognes Steve E. director | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 2,932 | Dec 2, 2024 |
| Dec 1, 2024 | Kalia Kumud Chief Information Officer | MOption exercise Restricted Stock Unitsderivative | -710 | $0.00 | $0 | 2,131 | Dec 2, 2024 |
| Dec 1, 2024 | Chudova Darya Chief Technology Officer | MOption exercise Restricted Stock Unitsderivative | -316 | $0.00 | $0 | 947 | Dec 2, 2024 |
| Dec 1, 2024 | Saia John G. Chief Legal Officer | MOption exercise Restricted Stock Unitsderivative | -263 | $0.00 | $0 | 790 | Dec 2, 2024 |
| Nov 18, 2024 | Kalia Kumud Chief Information Officer | SOpen-market sale Common Stock | -7,000 | $29.25 | $205k | 17,744 | Nov 19, 2024 |
| Nov 15, 2024 | POTTER MYRTLE S director | MOption exercise Common Stock | +68 | $0.00 | $0 | 13,653 | Nov 18, 2024 |
| Nov 15, 2024 | Tariq Musa director | MOption exercise Common Stock | +250 | $0.00 | $0 | 4,996 | Nov 18, 2024 |
| Nov 15, 2024 | Tariq Musa director | MOption exercise Restricted Stock Unitsderivative | -250 | $0.00 | $0 | 6,996 | Nov 18, 2024 |
| Nov 15, 2024 | POTTER MYRTLE S director | MOption exercise Restricted Stock Unitsderivative | -68 | $0.00 | $0 | 753 | Nov 18, 2024 |
| Nov 13, 2024 | Joyce Meghan V. director | SOpen-market sale Common Stock10b5-1 | -2,896 | $29.90 | $87k | 7,648 | Nov 14, 2024 |
| Nov 12, 2024 | CLARK IAN T director | MOption exercise Common Stock | +1,076 | $4.18 | $4,498 | 16,753 | Nov 14, 2024 |
| Nov 12, 2024 | CLARK IAN T director | SOpen-market sale Common Stock | -1,076 | $29.52 | $32k | 15,677 | Nov 14, 2024 |
| Nov 12, 2024 | CLARK IAN T director | SOpen-market sale Common Stock | -7,242 | $29.44 | $213k | 8,435 | Nov 14, 2024 |
| Nov 12, 2024 | CLARK IAN T director | JOther Common Stock | -8,435 | $0.00 | $0 | 0 | Nov 14, 2024 |
| Nov 12, 2024 | CLARK IAN T director | JOther Common Stockindirect: By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account | +8,435 | $0.00 | $0 | 8,435 | Nov 14, 2024 |
| Nov 12, 2024 | CLARK IAN T director | MOption exercise Stock Option (Right to Buy)derivative | -1,076 | $0.00 | $0 | 0 | Nov 14, 2024 |
| Nov 8, 2024 | Kalia Kumud Chief Information Officer | AGrant or award Stock Option (Right to Buy)derivative | +35,721 | $0.00 | $0 | 35,721 | Nov 12, 2024 |
| Nov 8, 2024 | MIGNONE ROBERTO director | AGrant or award Stock Option (Right to Buy)derivative | +19,535 | $0.00 | $0 | 19,535 | Nov 12, 2024 |
| Nov 8, 2024 | Monroe Terilyn J. Chief People Officer | AGrant or award Stock Option (Right to Buy)derivative | +47,627 | $0.00 | $0 | 47,627 | Nov 12, 2024 |
| Nov 8, 2024 | Freeman Chris Chief Commercial Officer | AGrant or award Stock Option (Right to Buy)derivative | +45,246 | $0.00 | $0 | 45,246 | Nov 12, 2024 |
| Nov 8, 2024 | EAGLE CRAIG Chief Medical Officer | AGrant or award Stock Option (Right to Buy)derivative | +47,627 | $0.00 | $0 | 47,627 | Nov 12, 2024 |
| Nov 8, 2024 | Saia John G. Chief Legal Officer | AGrant or award Stock Option (Right to Buy)derivative | +52,389 | $0.00 | $0 | 52,389 | Nov 12, 2024 |
| Nov 8, 2024 | Chudova Darya Chief Technology Officer | AGrant or award Stock Option (Right to Buy)derivative | +59,534 | $0.00 | $0 | 59,534 | Nov 12, 2024 |
| Nov 8, 2024 | Bell Michael Brian Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +59,534 | $0.00 | $0 | 59,534 | Nov 12, 2024 |
| Nov 8, 2024 | Monroe Terilyn J. Chief People Officer | AGrant or award Restricted Stock Unitsderivative | +31,751 | $0.00 | $0 | 31,751 | Nov 12, 2024 |
| Nov 8, 2024 | Saia John G. Chief Legal Officer | AGrant or award Restricted Stock Unitsderivative | +34,926 | $0.00 | $0 | 34,926 | Nov 12, 2024 |
| Nov 8, 2024 | MIGNONE ROBERTO director | AGrant or award Restricted Stock Unitsderivative | +12,671 | $0.00 | $0 | 12,671 | Nov 12, 2024 |
| Nov 8, 2024 | Kalia Kumud Chief Information Officer | AGrant or award Restricted Stock Unitsderivative | +23,814 | $0.00 | $0 | 23,814 | Nov 12, 2024 |
| Nov 8, 2024 | Freeman Chris Chief Commercial Officer | AGrant or award Restricted Stock Unitsderivative | +30,164 | $0.00 | $0 | 30,164 | Nov 12, 2024 |
| Nov 8, 2024 | EAGLE CRAIG Chief Medical Officer | AGrant or award Restricted Stock Unitsderivative | +31,751 | $0.00 | $0 | 31,751 | Nov 12, 2024 |
| Nov 8, 2024 | Chudova Darya Chief Technology Officer | AGrant or award Restricted Stock Unitsderivative | +39,689 | $0.00 | $0 | 39,689 | Nov 12, 2024 |
| Nov 8, 2024 | Bell Michael Brian Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +39,689 | $0.00 | $0 | 39,689 | Nov 12, 2024 |
| Nov 4, 2024 | Chudova Darya Chief Technology Officer | MOption exercise Common Stock | +9,756 | $0.00 | $0 | 59,570 | Nov 5, 2024 |
| Nov 4, 2024 | Joyce Meghan V. director | MOption exercise Common Stock | +66 | $0.00 | $0 | 10,544 | Nov 5, 2024 |
| Nov 4, 2024 | Chudova Darya Chief Technology Officer | FTax withholding Common Stock | -4,945 | $23.60 | $117k | 54,625 | Nov 5, 2024 |
| Nov 4, 2024 | Joyce Meghan V. director | MOption exercise Restricted Stock Unitsderivative | -66 | $0.00 | $0 | 598 | Nov 5, 2024 |
| Nov 4, 2024 | Chudova Darya Chief Technology Officer | MOption exercise Restricted Stock Unitsderivative | -9,756 | $0.00 | $0 | 0 | Nov 5, 2024 |
| Oct 31, 2024 | Krognes Steve E. director | MOption exercise Common Stock | +154 | $0.00 | $0 | 9,911 | Nov 4, 2024 |
| Oct 31, 2024 | Krognes Steve E. director | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 3,086 | Nov 4, 2024 |
| Oct 15, 2024 | POTTER MYRTLE S director | MOption exercise Common Stock | +69 | $0.00 | $0 | 13,585 | Oct 16, 2024 |
| Oct 15, 2024 | Tariq Musa director | MOption exercise Common Stock | +250 | $0.00 | $0 | 4,746 | Oct 16, 2024 |
| Oct 15, 2024 | POTTER MYRTLE S director | MOption exercise Restricted Stock Unitsderivative | -69 | $0.00 | $0 | 821 | Oct 16, 2024 |
| Oct 15, 2024 | Tariq Musa director | MOption exercise Restricted Stock Unitsderivative | -250 | $0.00 | $0 | 7,246 | Oct 16, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Bell Michael BrianChief Financial Officer
- CLARK IAN Tdirector
- Chudova DaryaChief Technology Officer
- EAGLE CRAIGChief Medical Officer
- Freeman ChrisChief Commercial Officer
- Joyce Meghan V.director
- Kalia KumudChief Information Officer
- Krognes Steve E.director
- MIGNONE ROBERTOdirector
- Monroe Terilyn J.Chief People Officer
- POTTER MYRTLE Sdirector
- Saia John G.Chief Legal Officer
- Tariq Musadirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.